KMT2A and leukemia: Remarkably, MSI2 controlled pathways in LSCs and MLL1-HOXA9-MEIS1 leukemia programs were selectively enriched in GE independent LSC unique targets, which are expressed at the same or lower level in LSKs (Fig. 3k, Supplementary Data 3).